EGFR and MUC1 as dual-TAA drug targets for lung cancer and colorectal cancer

EGFR and MUC1 as dual-TAA drug targets for lung cancer and colorectal cancer

BackgroundEpidermal growth factor receptor (EGFR) is a key protein in cellular signaling that is overexpressed in many human cancers, making it a compelling therapeutic target. On-target severe skin toxicity has limited its clinical application. Dual-targeting therapy represents a novel approach to...

Full description

Saved in:
Bibliographic Details
Main Authors: Huilin Cui, Qianqian Yu, Qumiao Xu, Chen Lin, Long Zhang, Wei Ye, Yifei Yang, Sijia Tian, Yilu Zhou, Runzhe Sun, Yongsheng Meng, Ningning Yao, Haizhen Wang, Feilin Cao, Meilin Liu, Jinfeng Ma, Cheng Liao, Ruifang Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Oncology
Subjects:
EGFR
MUC1
TAA
LUAD
CRC
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1433033/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1433033/full

Similar Items